egtazic acid has been researched along with Experimental Mammary Neoplasms in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Esumi-Kurisu, M; Mizuno, D; Yamazaki, M | 1 |
Asea, A; Calderwood, SK; Kabingu, E; Stevenson, MA | 1 |
Steiner, MR | 1 |
Allen, R; Bologna, M; Dulbecco, R | 1 |
Borsos, T; Glenn, G; Nakanishi, K; Zbar, B | 1 |
Borsos, T; Nakanishi, K; Zbar, B | 1 |
6 other study(ies) available for egtazic acid and Experimental Mammary Neoplasms
Article | Year |
---|---|
The role of divalent cations in antibody-dependent macrophage-mediated tumor lysis.
Topics: Animals; Antibodies; Calcium; Cations, Divalent; Cytotoxicity, Immunologic; Edetic Acid; Egtazic Acid; Female; Macrophages; Magnesium; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains | 1980 |
HSP70 peptidembearing and peptide-negative preparations act as chaperokines.
Topics: Adenocarcinoma; Animals; Calcium; Chelating Agents; Egtazic Acid; Female; HSP70 Heat-Shock Proteins; Interleukin-1; Interleukin-6; Lipopolysaccharides; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Molecular Chaperones; Monocytes; NF-kappa B; Protein Binding; Signal Transduction; Spleen; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2000 |
Localization and characterization of phospholipase A2 in mouse mammary gland-derived cells.
Topics: Animals; Calcium Chloride; Cell Line; Cell-Free System; Egtazic Acid; Female; Kinetics; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Phospholipases A; Phospholipases A2; Substrate Specificity | 1991 |
Organization of cytokeratin bundles by desmosomes in rat mammary cells.
Topics: Animals; Cell Line; Cycloheximide; Cytoskeletal Proteins; Cytoskeleton; Desmoplakins; Desmosomes; Egtazic Acid; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique; HeLa Cells; Humans; Intermediate Filaments; Keratins; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Membrane Proteins; Rats; Time Factors | 1986 |
Serotherapy of primary rat mammary carcinoma: inhibition by ethylenedinitrilotetraacetic acid but not by [ethylenebis(oxyethylenenitrilo)]tetraacetic acid.
Topics: Animals; Calcium; Complement C3; Complement Pathway, Alternative; Edetic Acid; Egtazic Acid; Ethylene Glycols; Female; Immunization, Passive; Magnesium; Mammary Neoplasms, Experimental; Rats; Rats, Inbred BN; Sepharose; Staphylococcal Protein A | 1986 |
Plasma therapy of primary rat mammary carcinoma: dependence of consumption of C3 during absorption of plasma with sepharose derivatives on the anticoagulant.
Topics: Absorption; Animals; Anticoagulants; Complement C3; Complement System Proteins; Edetic Acid; Egtazic Acid; Female; Magnesium; Mammary Neoplasms, Experimental; Rats; Sepharose; Staphylococcal Protein A; Temperature; Time Factors | 1985 |